0.77  -0.014 (-1.79%)		07-16 16:00
Open: 0.77 High: 0.77 Volume: 3,000		Pre. Close: 0.784 Low: 0.77 Market Cap: 18(M)

Short term
Mid term
Targets	6-month :	0.93	1-year :	1.09
Resists	First :	0.8	Second :	0.93
Pivot price	0.77
Supports	First :	0.67	Second :	0.6
MAs	MA(5) :	0.77	MA(20) :	0.76
	MA(100) :	0.65	MA(250) :	0.61
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	65.9	D(3) :	70.9
RSI	RSI(14): 52.1
52-week	High :	0.98	Low :	0.28

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PETV ] has closed above bottom band by 44.5%. Bollinger Bands are 60.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.77 - 0.78	0.78 - 0.78
Low:	0.76 - 0.77	0.77 - 0.77
Close:	0.76 - 0.77	0.77 - 0.78

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Mon, 07 Jul 2025
PetVivo Holdings, Inc. (OTC:PETV) Q4 2025 Earnings Call Transcript - MSN

Thu, 03 Jul 2025
PetVivo Holdings, Inc. (OTC:PETV) Q4 2025 Earnings Call Transcript - Insider Monkey

Wed, 02 Jul 2025
Petvivo Holdings Inc. Reports Cautious Optimism in Earnings Call - TipRanks

Mon, 30 Jun 2025
PetVivo Holdings Reports Record Growth and Strategic Advances - TipRanks

Mon, 30 Jun 2025
PetVivo Reports Fiscal 2025 Results - Yahoo Finance

Thu, 26 Jun 2025
PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: OTC
Sector: Healthcare
Industry: Medical - Devices
Shares Out	-4 (M)
Shares Float	0 (M)
Held by Insiders	2e+007 (%)
Held by Institutions	1.514e+007 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.64
Profit Margin	0 %
Operating Margin	-1 %
Return on Assets (ttm)	652 %
Return on Equity (ttm)	-204 %
Qtrly Rev. Growth	646.7 %
Gross Profit (p.s.)	7.46
Sales Per Share	118.42
EBITDA (p.s.)	0
Qtrly Earnings Growth	-9.64e+006 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	-1.21
Price to Sales	0
Price to Cash Flow	0

Dividend	129100
Forward Dividend	128080
Dividend Yield	16766200%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.